Current Issue

Data as an Asset: What Does this Mean to You?

Christos Varsakelis, Team Lead Artificial Intelligence/Machine Learning, The Janssen Pharm...

Developing a Leading Edge with PAT

Martin Gadsby, Owner, Optimal Industrial Automation Ltd

Risk-Based Extractable Data Assessment and its Application to the Evaluation of Materials ...

Ping Wang Ph.D., MBA, Scientific Director, Janssen

Supply Chain Security Risks

Brian Johnson, Senior Director of Supply Chain Security, Pfizer Pharmaceuticals / Chair o...

Applications of SFC in Pharmaceutical Analysis

Gregory Webster, Senior Principal Research Scientist, AbbVie Inc

Transforming Scientists into Drug Developers

Clive Glover, General Manager, Gene Therapy, Pall James Taylor, Co-founder and GM, Precisi...


Inspiring the Next Generation at Bristol Myers Squibb

Elizabeth Jurica, Bristol Myers Squibb, Principal Scientist

A Great Working Atmosphere, Strong Collegial Relationships, and Opportunities to Grow at Lonza

Vijetha Bhat, Lonza, Houston,Texas, Scientist, Research and Development

At Bayer We Foster an Environment of Openness and Understanding Not Pity

Jürgen Schrapp, Bayer, Head of R&D Procurement

The Best Thing About Evotec, Without Question, Is The People

Stuart Flanagan, Evotec, Group Leader

At Boehringer Ingelheim, I am a Molecular Architect…

Alexander M. Haydl, Boehringer Ingelheim Germany, Head of Late-Stage Development Laboratory and Product Owner of Digital Process Development

We Support each other to Develop and Grow at Novartis

Jennifer Snyder, Novartis Pharmaceuticals, Director, Portfolio Strategy Management for Technical Research and Development Cell & Gene Therapy

View All Careers Articles

Headline News

FDA Lifts Clinical Hold on Investigational Lenacapavir for the Treatment and Prevention of HIV

FDA approves Lilly’s Mounjaro™ injection, the first and only GIP and GLP-1 receptor agonist for the treatment of adults with type 2 diabetes

Merck To Present Data at 2022 ASCO Annual Meeting Highlighting Promising Pipeline Medicines and Significant Progress in Treating Earlier Stages of Certain Cancers With KEYTRUDA® (pembrolizumab)

Read All Headlines

Upcoming Webinars

ICH Q3E Impurity Guidelines: Assessment and Control of Extractractables and Leachables for Pharmaceuticals and Biologics.

Presented by Jason Creasey, Managing Director at Maven E&L Ltd and Piet Christiaens, PhD, Scientific Director at Nelson Labs
14th September 2022

Batch to Continuous Technology: The Journey from Laboratory to Pilot Scale for DS Manufacturing

Presented by Jörg Sedelmeier, Platform Leader: Continuous flow technology (Principal Scientist) at Roche
26th September 2022

Best Practices of Downstream Protein Purification and Product Concentration

Presented by Krishnamurthy Venkatesan, Downstream MSAT Lead, Director at Biocon Biologics.
12th October 2022

View All Upcoming Webinars

Past Webinars

Validation Of Endotoxin Testing For CAR T-cell Manufacturing Quality Control & Benefits of Cartridge Technology

Presented by Dr. Zlatibor Velickovic PhD Production Manager | Department of Cell & Molecular Therapies, Royal Prince Alfred Hospital Sydney, Australia, ISCT Regional Vice-President Elect, Australia & New Zealand and Alan Hoffmeister Senior Global Technology & Market Development Manager, Charles River Laboratories
28th October 2021

Identification of unknown extractables and leachables using mass spectrometry: Identification with confidence?

Presented by Petra Booij, Investigator at GlaxoSmithKline and Dr Kyle D’Silva, Pharma & BioPharma Marketing Leader, Thermo Fisher Scientific
30th January 2020

Challenges and Risks in Development and Manufacture of Covid 19 Vaccines

Presented by Rajesh K. Gupta, Ph.D. Biologics Quality & Regulatory Consultants, LLC, North Potomac, Harish Rao, General Manager at Serum Institute of India Ltd, Amar Shrivastava, Senior Manager  at Serum Institute of India Ltd
30th June 2020

View All Past Webinars

Featured Companies


View All Companies

© 2022 All rights reserved. Privacy Policy